2 news items
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
OVID
14 May 24
to measure target engagement and clinical efficacy. The single-ascending dose portion is complete and no safety signals were observed. The multiple
Cracking The Code: Understanding Analyst Reviews For Ovid Therapeutics
OVID
7 May 24
and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate
- Prev
- 1
- Next